東華大學圖書館 |

Role of microorganisms in pathogenesis and management of autoimmune diseases.. Volume II,. Kidney, central nervous system, eye, blood, blood vessels & bowel

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Role of microorganisms in pathogenesis and management of autoimmune diseases./ edited by Mitesh Kumar Dwivedi ... [et al.].
其他題名:	Kidney, central nervous system, eye, blood, blood vessels & bowel
其他作者:	Dwivedi, Mitesh Kumar.
出版者:	Singapore :Springer Nature Singapore : : 2022.,
面頁冊數:	xxi, 542 p. :ill., digital ;24 cm.
內容註:	PART I: HUMAN MICROBIOME, VACCINES AND AUTOIMMUNITY -- Chapter 1. Autoimmunity and Microbiome -- Chapter 2. The vaccines induced autoimmunity -- Chapter 3. COVID-19 and Autoimmunity -- Chapter 4. The protective discourse between infections and autoimmunity -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE KIDNEY DISEASES & ADRENAL INSUFFICIENCY -- Chapter 5. Microorganisms in pathogenesis and management of Anti-Neutrophil Cytoplasmic Antibody- (ANCA)- Associated Vasculitis -- Chapter 6. Microorganisms in pathogenesis and management of IgA Vasculitis and IgA Nephropathy -- Chapter 7. Microorganisms in pathogenesis and management of immune mediated glomerulopathies -- Chapter 8. Microorganisms in pathogenesis and management of Autoimmune Addison's Disease (ADD) -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF CENTRAL NERVOUS SYSTEM (CNS) DEMYELINATING AUTOIMMUNE DISEASES -- Chapter 9. Microorganisms in pathogenesis and management of Multiple Sclerosis (MS) -- Chapter 10. Microorganisms in pathogenesis and management of Guillain-Barre syndrome (GBS) -- Chapter 11. Microorganisms in pathogenesis and management of Neuromyelitis Optica -- Chapter 12. Microorganisms in pathogenesis and management of Acute Disseminated Encephalomyelitis (ADEM) -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBDs) -- Chapter 13. Microorganisms in pathogenesis and management of Ulcerative colitis (UC) -- Chapter 14. Microorganisms in pathogenesis and management of Crohn's disease (CD) -- Chapter 15. Microorganisms in pathogenesis and management of Pouchitis -- Chapter 16. Microorganisms in pathogenesis and management of Coeliac Disease -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE BLOOD & BLOOD VESSEL DISORDERS -- Chapter 17. Microorganisms in pathogenesis and management of Anti-Phospholipid Syndrome (Hughes syndrome) -- Chapter 18. Microorganisms in pathogenesis and management of Behçet Disease (BD) -- Chapter 19. Microorganisms in pathogenesis and management of Immune Thrombocytopenia -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE EYE DISEASES -- Chapter 20. Microorganisms in pathogenesis and management of Autoimmune Uveitis -- Chapter 21. Microorganisms in pathogenesis and management of Autoimmune Retinopathy (AIR) -- Chapter 22. Microorganisms in pathogenesis and management of Type 1 Diabetes (T1D) -- Chapter 23. The influence of the microbiome and genetic associations on immune functions and on autoimmune and autoinflammatory diseases -- Chapter 24. Current challenges in research with exploring the microbial pathomechanisms of Autoimmune diseases -- Chapter 25. Future therapeutic prospects in dealing with autoimmune diseases: Treatment Based on the Microbiome Model.
Contained By:	Springer Nature eBook
標題:	Autoimmune diseases - Pathogenesis. -
電子資源:	https://doi.org/10.1007/978-981-19-4800-8
ISBN:	9789811948008

Role of microorganisms in pathogenesis and management of autoimmune diseases.. Volume II,. Kidney, central nervous system, eye, blood, blood vessels & bowel
Role of microorganisms in pathogenesis and management of autoimmune diseases.Volume II,Kidney, central nervous system, eye, blood, blood vessels & bowel[electronic resource] /Kidney, central nervous system, eye, blood, blood vessels & boweledited by Mitesh Kumar Dwivedi ... [et al.]. - Singapore :Springer Nature Singapore :2022. - xxi, 542 p. :ill., digital ;24 cm.

PART I: HUMAN MICROBIOME, VACCINES AND AUTOIMMUNITY -- Chapter 1. Autoimmunity and Microbiome -- Chapter 2. The vaccines induced autoimmunity -- Chapter 3. COVID-19 and Autoimmunity -- Chapter 4. The protective discourse between infections and autoimmunity -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE KIDNEY DISEASES & ADRENAL INSUFFICIENCY -- Chapter 5. Microorganisms in pathogenesis and management of Anti-Neutrophil Cytoplasmic Antibody- (ANCA)- Associated Vasculitis -- Chapter 6. Microorganisms in pathogenesis and management of IgA Vasculitis and IgA Nephropathy -- Chapter 7. Microorganisms in pathogenesis and management of immune mediated glomerulopathies -- Chapter 8. Microorganisms in pathogenesis and management of Autoimmune Addison's Disease (ADD) -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF CENTRAL NERVOUS SYSTEM (CNS) DEMYELINATING AUTOIMMUNE DISEASES -- Chapter 9. Microorganisms in pathogenesis and management of Multiple Sclerosis (MS) -- Chapter 10. Microorganisms in pathogenesis and management of Guillain-Barre syndrome (GBS) -- Chapter 11. Microorganisms in pathogenesis and management of Neuromyelitis Optica -- Chapter 12. Microorganisms in pathogenesis and management of Acute Disseminated Encephalomyelitis (ADEM) -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBDs) -- Chapter 13. Microorganisms in pathogenesis and management of Ulcerative colitis (UC) -- Chapter 14. Microorganisms in pathogenesis and management of Crohn's disease (CD) -- Chapter 15. Microorganisms in pathogenesis and management of Pouchitis -- Chapter 16. Microorganisms in pathogenesis and management of Coeliac Disease -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE BLOOD & BLOOD VESSEL DISORDERS -- Chapter 17. Microorganisms in pathogenesis and management of Anti-Phospholipid Syndrome (Hughes syndrome) -- Chapter 18. Microorganisms in pathogenesis and management of Behçet Disease (BD) -- Chapter 19. Microorganisms in pathogenesis and management of Immune Thrombocytopenia -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE EYE DISEASES -- Chapter 20. Microorganisms in pathogenesis and management of Autoimmune Uveitis -- Chapter 21. Microorganisms in pathogenesis and management of Autoimmune Retinopathy (AIR) -- Chapter 22. Microorganisms in pathogenesis and management of Type 1 Diabetes (T1D) -- Chapter 23. The influence of the microbiome and genetic associations on immune functions and on autoimmune and autoinflammatory diseases -- Chapter 24. Current challenges in research with exploring the microbial pathomechanisms of Autoimmune diseases -- Chapter 25. Future therapeutic prospects in dealing with autoimmune diseases: Treatment Based on the Microbiome Model.

This book, which is the second volume of Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases, provides comprehensive coverage on how microbial pathogens can subvert our immune system into responding against self and resulting in autoimmune diseases. In particular, the book covers the different aspects of linking gut microbiota dysbiosis with autoimmune mechanisms involved in disease development to identify future effective approaches based on the gut microbiota for preventing these autoimmune diseases. Contributions in the book focus on the role of microbiota/probiotics and their distinct mechanisms exerted in the management of autoimmune diseases of the kidney, central nervous system, eye, blood vessel, and bowel. This could help in better understanding to design of therapeutic strategies that can be deployed to prevent these autoimmune diseases. The book has an interdisciplinary appeal and scholars with an interest in immunology, medical microbiology, and nutritional sciences will value its contribution. Overall, the book gives new dimension and insight into the aspects of microbial role in autoimmune disease pathogenesis.

ISBN: 9789811948008

Standard No.: 10.1007/978-981-19-4800-8doiSubjects--Topical Terms:

3603721
Autoimmune diseases
--Pathogenesis.

LC Class. No.: RC600 / .R65 2022

Dewey Class. No.: 616.978

Role of microorganisms in pathogenesis and management of autoimmune diseases.. Volume II,. Kidney, central nervous system, eye, blood, blood vessels & bowel
LDR:05177nmm a2200337 a 4500 001 2306724
003 DE-He213
005 20221220154010.0
006 m d
007 cr nn 008maaau
008 230421s2022 si s 0 eng d
020 $a 9789811948008 $q (electronic bk.)
020 $a 9789811947995 $q (paper)
024 7 $a 10.1007/978-981-19-4800-8 $2 doi
035 $a 978-981-19-4800-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC600 $b .R65 2022
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 616.978 $2 23
090 $a RC600 $b .R745 2022
245 0 0 $a Role of microorganisms in pathogenesis and management of autoimmune diseases. $n Volume II, $p Kidney, central nervous system, eye, blood, blood vessels & bowel $h [electronic resource] / $c edited by Mitesh Kumar Dwivedi ... [et al.].
246 3 0 $a Kidney, central nervous system, eye, blood, blood vessels & bowel
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a xxi, 542 p. : $b ill., digital ; $c 24 cm.
505 0 $a PART I: HUMAN MICROBIOME, VACCINES AND AUTOIMMUNITY -- Chapter 1. Autoimmunity and Microbiome -- Chapter 2. The vaccines induced autoimmunity -- Chapter 3. COVID-19 and Autoimmunity -- Chapter 4. The protective discourse between infections and autoimmunity -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE KIDNEY DISEASES & ADRENAL INSUFFICIENCY -- Chapter 5. Microorganisms in pathogenesis and management of Anti-Neutrophil Cytoplasmic Antibody- (ANCA)- Associated Vasculitis -- Chapter 6. Microorganisms in pathogenesis and management of IgA Vasculitis and IgA Nephropathy -- Chapter 7. Microorganisms in pathogenesis and management of immune mediated glomerulopathies -- Chapter 8. Microorganisms in pathogenesis and management of Autoimmune Addison's Disease (ADD) -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF CENTRAL NERVOUS SYSTEM (CNS) DEMYELINATING AUTOIMMUNE DISEASES -- Chapter 9. Microorganisms in pathogenesis and management of Multiple Sclerosis (MS) -- Chapter 10. Microorganisms in pathogenesis and management of Guillain-Barre syndrome (GBS) -- Chapter 11. Microorganisms in pathogenesis and management of Neuromyelitis Optica -- Chapter 12. Microorganisms in pathogenesis and management of Acute Disseminated Encephalomyelitis (ADEM) -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBDs) -- Chapter 13. Microorganisms in pathogenesis and management of Ulcerative colitis (UC) -- Chapter 14. Microorganisms in pathogenesis and management of Crohn's disease (CD) -- Chapter 15. Microorganisms in pathogenesis and management of Pouchitis -- Chapter 16. Microorganisms in pathogenesis and management of Coeliac Disease -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE BLOOD & BLOOD VESSEL DISORDERS -- Chapter 17. Microorganisms in pathogenesis and management of Anti-Phospholipid Syndrome (Hughes syndrome) -- Chapter 18. Microorganisms in pathogenesis and management of Behçet Disease (BD) -- Chapter 19. Microorganisms in pathogenesis and management of Immune Thrombocytopenia -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE EYE DISEASES -- Chapter 20. Microorganisms in pathogenesis and management of Autoimmune Uveitis -- Chapter 21. Microorganisms in pathogenesis and management of Autoimmune Retinopathy (AIR) -- Chapter 22. Microorganisms in pathogenesis and management of Type 1 Diabetes (T1D) -- Chapter 23. The influence of the microbiome and genetic associations on immune functions and on autoimmune and autoinflammatory diseases -- Chapter 24. Current challenges in research with exploring the microbial pathomechanisms of Autoimmune diseases -- Chapter 25. Future therapeutic prospects in dealing with autoimmune diseases: Treatment Based on the Microbiome Model.
520 $a This book, which is the second volume of Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases, provides comprehensive coverage on how microbial pathogens can subvert our immune system into responding against self and resulting in autoimmune diseases. In particular, the book covers the different aspects of linking gut microbiota dysbiosis with autoimmune mechanisms involved in disease development to identify future effective approaches based on the gut microbiota for preventing these autoimmune diseases. Contributions in the book focus on the role of microbiota/probiotics and their distinct mechanisms exerted in the management of autoimmune diseases of the kidney, central nervous system, eye, blood vessel, and bowel. This could help in better understanding to design of therapeutic strategies that can be deployed to prevent these autoimmune diseases. The book has an interdisciplinary appeal and scholars with an interest in immunology, medical microbiology, and nutritional sciences will value its contribution. Overall, the book gives new dimension and insight into the aspects of microbial role in autoimmune disease pathogenesis.
650 0 $a Autoimmune diseases $x Pathogenesis. $3 3603721
650 0 $a Autoimmune diseases $x Treatment. $3 1002926
650 0 $a Microbial ecology. $3 555211
700 1 $a Dwivedi, Mitesh Kumar. $3 3603720
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-4800-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)